Nymox Pharmaceutical Corp SMA 200
What is the SMA 200 of Nymox Pharmaceutical Corp?
The SMA 200 of Nymox Pharmaceutical Corp is $0 -59.99%
What is the definition of SMA 200?
SMA 200 is an average stock price from the last 200 days calculated as an unweighted mean of the previous 200 stock closing prices.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 of companies in the Health Care sector on NASDAQ compared to Nymox Pharmaceutical Corp
What does Nymox Pharmaceutical Corp do?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Companies with sma 200 similar to Nymox Pharmaceutical Corp
- Wattle Health Australia has SMA 200 of AUD$0 -374.63%
- Vongroup has SMA 200 of $0 -9.71%
- Top Form International has SMA 200 of HKD$0 -27.40%
- SomnoMed has SMA 200 of AUD$0 +29.12%
- Aurania Resources has SMA 200 of CAD$0 +40.79%
- ENM has SMA 200 of HKD$0 -18.49%
- Nymox Pharmaceutical Corp has SMA 200 of $0 -59.99%
- Titan Petrochemicals has SMA 200 of HKD$0 +96.91%
- AAJ Capital 2 has SMA 200 of CAD$0 +99.29%
- Advantagewon Oil has SMA 200 of $0 -70.21%
- Buderim has SMA 200 of AUD$0 +98.90%
- Whispir has SMA 200 of $0 +1.45%
- Srhi Inc has SMA 200 of CAD$0 +31.18%